The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment

This trial was conducted to investigate the long-term effects of proton pump inhibitor (PPI) coadministration on the efficacy of weekly risedronate treatment for osteoporosis. Ninety-six women over 50 years old with low bone mineral density (BMD) participated in this trial. Subjects were randomly di...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Mizue, Itoh, Soichiro, Yoshioka, Taro, Yamashita, Kimihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241743/
https://www.ncbi.nlm.nih.gov/pubmed/25436170
http://dx.doi.org/10.1155/2014/607145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241743/
https://www.ncbi.nlm.nih.gov/pubmed/25436170
http://dx.doi.org/10.1155/2014/607145

Ejemplares similares